Story · Medicine & Biotech · Health Tech

Samra Turajlić: Fully Funded MB-PhD Targets Tumour-Immune Vulnerabilities With AI

1 outlet · first reported by OncoDaily on

Samra Turajlić, Director of the Cancer Research UK Manchester Institute, Consultant Oncologist at The Christie and Professor at the University of Manchester, shared on LinkedIn: “Calling medical students at the (OncoDaily)

Coverage, in order

  1. OncoDaily obscure
    Samra Turajlić: Fully Funded MB-PhD Targets Tumour-Immune Vulnerabilities With AI

    Samra Turajlić, Director of the Cancer Research UK Manchester Institute, Consultant Oncologist at The Christie and Professor at the University of Manchester, shared on LinkedIn: “Calling medical students at the

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.